University of Wisconsin School of Medicine and Public Health
A Placebo-Controlled, Double-Blind, Parallel-Group, 24-Month Study to evaluate the efficacy and safety of E2609 in subjects with Early Alzheimer’s Disease
The PI of this project was:
This project was funded by: Eisai Inc.
The term of this project was: June 2017 to January 2020
The number of subjects scanned during this project was: 10